Seizure Treatment Articles & Analysis
5 news found
CIRM grant awarded to accelerate clinical trial of NRTX-1001, a promising regenerative neuronal cell therapy in adults with drug-resistant seizures NRTX-1001 is the first human cell therapy candidate to enter clinical investigation for the treatment of epilepsy Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell ...
NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for “adjunctive use for reducing the frequency of seizures in individuals 18 years of age or older diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary generalization, that are ...
Belgian health tech startup epihunter NV is awarded a $200,000 grant from Epilepsy Foundation to further validate and market their CE labelled epileptic seizure detection algorithm. “The objective seizure data collected by epihunter can help clinicians make more informed treatment decisions,” says Dr Alexander Rotenberg, neurologist ...
Belgian startup, epihunter, introduces automated video functionality to their CE-marked seizure detection app - a breakthrough for children and adults with epilepsy, their families and doctors. “Including video in epileptic seizure detection has the potential to change the way neurologists and epileptologists assess and document seizure frequency and the effect of therapy,” says Dr ...
“Including video in epileptic seizure detection has the potential to change the way neurologists and epileptologists assess and document seizure frequency and the effect of therapy,” says Dr Sándor Beniczky, Head of Clinical Neurophysiology at the Danish Epilepsy Centre. It is estimated that 1 in 100 people have epilepsy, and 1 in 3 people with epilepsy continue to experience ...